Anticoagulation and bleeding: a pooled analysis of lung cancer trials of the NCIC Clinical Trials Group. [electronic resource]
Producer: 20090728Description: 586-94 p. digitalISSN:- 1556-1380
- Aged
- Anti-Inflammatory Agents, Non-Steroidal -- administration & dosage
- Anticoagulants -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Female
- Hemorrhage -- chemically induced
- Heparin, Low-Molecular-Weight -- administration & dosage
- Humans
- Lung Diseases -- chemically induced
- Lung Neoplasms -- drug therapy
- Male
- Prognosis
- Randomized Controlled Trials as Topic
- Retrospective Studies
- Risk Factors
- Venous Thromboembolism -- chemically induced
- Warfarin -- administration & dosage
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.